Home / Immunoglobulins, Normal Human, for Intravascular Adm. / Italy
IT ATC J06BA02 · updated 2 Nov 2026
Immunoglobulins, Normal Human, for Intravascular Adm. shortage in Italy
Is there an Immunoglobulins, Normal Human, for Intravascular Adm. shortage in Italy?
Yes. As of 2 Nov 2026, 17 Immunoglobulins, Normal Human, for Intravascular Adm. products are reported short in Italy, the first since 10 Apr 2019. The company estimate for the return is 31 Dec 2026 (latest 1 Mar 2027). Main reason: increased demand.
Also short in Spain, Austria, Belgium, Switzerland, Sweden. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | KIOVIG discontinuation | TAKEDA MANUFACTURING AUSTRIA AG | 10 Apr 2019 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | KIOVIG discontinuation | TAKEDA MANUFACTURING AUSTRIA AG | 10 Apr 2019 | not given | Commercial decision or withdrawal Motivi commerciali: forniture discontinue |
| IT | IG VENA discontinuation | KEDRION S.P.A. | 31 Jul 2019 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF discontinuation | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | FLEBOGAMMA DIF discontinuation | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF discontinuation | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF discontinuation | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF discontinuation | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF discontinuation | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF discontinuation | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Increased demand Elevata richiesta: forniture discontinue |
| IT | FLEBOGAMMA DIF discontinuation | INSTITUTO GRIFOLS S.A. | 26 Nov 2020 | 31 Dec 2026 | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | GAMMAGARD discontinuation | BAXALTA INNOVATIONS GMBH | 1 Jul 2022 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | GAMMAGARD discontinuation | BAXALTA INNOVATIONS GMBH | 31 Oct 2022 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | IQYMUNE | LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES | 1 Sep 2025 | 1 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | IQYMUNE | LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES | 1 Sep 2025 | 1 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | GAMUNEX | GRIFOLS DEUTSCHLAND GMBH | 14 Nov 2025 | 31 Dec 2026 | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | GAMUNEX discontinuation | GRIFOLS DEUTSCHLAND GMBH | 14 Nov 2025 | 31 Dec 2026 | Manufacturing problem Problemi produttivi: forniture discontinue |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.